Drug recall · November 17, 2021
Ezetimibe and Simvastatin Tablets recall
Why: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC: a) 51407-192-90, b) 51407-192-05
- Lots / codes
a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023
- Quantity
- a) 101 b) 145 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Distributed to two distributors located in AZ and MO
- Initiated
- October 14, 2021 · Voluntary: Firm initiated
- Classified
- November 9, 2021
- Reported
- November 17, 2021
- Ended
- November 10, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Simvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.